Analysts rate K2M shares: 5 facts

Seven firms gave K2M shares a consensus recommendation of “buy,” according to web breaking news.

Advertisement

Here are five facts:

 

1. The shares have an average one-year price target of $25.50.

 

2. K2M Director Carlos A. Ferrer purchased 38,924 company shares for a total value of nearly $500,015.

 

3. Dr. Ferrer currently owns 39,383 K2M shares.

 

4. On April 26, K2M shares opened at $16.75.

 

5. The market cap is $690.57 million.

 

More device news:
Wenzel Spine’s VariLift-LX on full US commercial launch: 5 key notes
4th patient in INSPIRE study experiences AIS grade improvement: 5 things to know
Life Spine to host physician workshop for new solutions launching in 2016 — 3 highlights

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.